Olmepres 40 mg (Tablet)
Unit Price: ৳ 17.00 (3 x 10: ৳ 509.85)
Strip Price: ৳ 169.95
Medicine Details
| Category | Details |
|---|---|
| Generic | Olmesartan medoxomil |
| Company | General pharmaceuticals ltd |
| Also available as |
Title
- Olmepres 40 mg Tablet
Categories
- Medicine
- Pharmaceuticals
- Healthcare
Description
- Indicated for the treatment of hypertension
- May be used alone or in combination with other antihypertensive agents
- Blocks the vasoconstrictor effects of angiotensin II
- Individualized dosage required
- Well-tolerated with low incidence of adverse reactions
- Recommended storage conditions
Dosage & Administration
- Starting dose of 20 mg once daily
- May be increased to 40 mg for further reduction in blood pressure
- May be administered with or without food
- No initial dosage adjustment recommended for elderly patients
Chemical Structure
- Molecular Formula: C29H30N6O6
- Chemical Structure Image URL: https://medex.com.bd/storage/res/g-res-822-olmesartan-medoxomil-chemical-structure-XdunPf7zhrREoTiawNhA.png
Therapeutic Class
- Angiotensin-II receptor blocker
Storage Conditions
- Store in cool & dry place below 30°C
- Protect from light & moisture
- Keep out of the reach of children
Pregnancy & Lactation
- Discontinue use when pregnancy is detected
- Potential excretion in human milk
- Adverse effects on nursing infant
Interaction
- No significant drug interactions reported in studies
- Bioavailability not significantly altered by antacids
- Not metabolized by cytochrome P450 system
Precautions & Warnings
- Changes in renal function may be anticipated
- Associated with oliguria and/or progressive azotemia
Overdose Effects
- No experience of overdose reported
- Likely effects: hypotension and tachycardia
Commonly Asked Questions
- Uses of Olmepres 40 mg Tablet
- Time taken to reach peak effect
- Frequency of usage
- Instructions for storage and disposal
- Quick tips for usage
Mode of Action
- Formation of angiotensin II from angiotensin I by angiotensin converting enzyme
- Principal pressor agent of the renin-angiotensin system
- Blocks the binding of angiotensin II to the AT 1 receptor
Contraindications
- Hypersensitivity to any component of the product
Side Effects
- Well-tolerated with incidence of adverse reactions similar to placebo
- Adverse reactions not dose-related
- Analysis shows no differences between Olmepres and placebo treated patients
Dosage Individualization
- Recommended for patients not volume-contracted
- Special considerations for elderly and patients with renal impairment
- Twice-daily dosing offers no advantage over once daily dosing